Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emily Lai-Ho MacLean"'
Autor:
Tom Wingfield, Rachel Forse, Jacob Creswell, Lina Davies Forsman, Kristi Sidney, Luan Nguyen Quang Vo, Andrew Codlin, Han Thi Nguyen, Emily Lai-Ho MacLean, Beatrice Kirubi
Publikováno v:
BMJ Open, Vol 14, Iss 8 (2024)
Introduction The large reservoir of tuberculosis (TB) infections is one of the main reasons for the persistent incidence of TB. Accurate diagnostic tests are crucial to correctly identify and treat people with TB infection, which is vital to eliminat
Externí odkaz:
https://doaj.org/article/2f283a55d69a4be386c9d79129b9b1ba
Publikováno v:
European Respiratory Review, Vol 33, Iss 172 (2024)
Background: This scoping review aimed to characterise definitions used to describe subclinical tuberculosis (TB), estimate the prevalence in different populations and describe the clinical characteristics and treatment outcomes in the scientific lite
Externí odkaz:
https://doaj.org/article/01a7c1bbe0f2429985f4c968df79c199
Autor:
Emily Lai-Ho MacLean, Paolo Miotto, Lice González Angulo, Matteo Chiacchiaretta, Timothy M Walker, Martina Casenghi, Camilla Rodrigues, Timothy C Rodwell, Philip Supply, Emmanuel André, Mikashmi Kohli, Morten Ruhwald, Daniela Maria Cirillo, Nazir Ismail, Matteo Zignol
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 3, p e0001754 (2023)
There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accu
Externí odkaz:
https://doaj.org/article/f2e3ac4950664f398da740532ca77b52
Autor:
Emily Lai-Ho MacLean, Luz Villa-Castillo, Patricia Espinoza-Lopez, Tatiana Caceres, Giorgia Sulis, Mikashmi Kohli, Madhukar Pai, César Ugarte-Gil
Publikováno v:
The Lancet Microbe. 4:e452-e460